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Abstract
Aims: The hereditary b-thalassemia major condition requires regular lifelong blood transfusions. Transfusion-related iron
overloading has been associated with the onset of cardiovascular complications, including cardiac dysfunction and vascular
anomalies. By using an untransfused murine model of b-thalassemia major, we tested the hypothesis that vascular
endothelial dysfunction, alterations of arterial structure and of its mechanical properties would occur despite the absence of
treatments.
Methods and Results: Vascular function and structure were evaluated ex vivo. Compared to the controls, endothelium-
dependent vasodilation with acetylcholine was blunted in mesenteric resistance arteries of b-thalassemic mice while the
endothelium-independent vasodilator (sodium nitroprusside) produced comparable vessel dilation, indicating endothelial
cell impairment with preserved smooth muscle cell reactivity to nitric oxide (NO). While these findings suggest a decrease in
NO bioavailability, Western blotting showed heightened expression of aortic endothelial NO synthase (eNOS) in b-
thalassemia. Vascular remodeling of the common carotid arteries revealed increased medial elastin content. Under isobaric
conditions, the carotid arteries of b-thalassemic mice exhibited decreased wall stress and softening due to structural
changes of the vessel wall.
Conclusions: A complex vasculopathy was identified in untransfused b-thalassemic mice characterized by altered carotid
artery structure and endothelial dysfunction of resistance arterioles, likely attributable to reduced NO bioavailability despite
enhanced vascular eNOS expression.
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Introduction
b-thalassemia is an inherited hemoglobin disorder resulting from
impairedproductionofb-globinchainsofthehemoglobintetramer.
The resultant phenotype is chronic hemolytic anemia of varying
severity, depending on the level of b-globin chain deficiency and
subsequent a-globin chain accumulation. b-thalassemia major is
characterizedbyseveretransfusion-dependentanemia,startingfrom
thefirstyearoflife,whereasb-thalassemiaintermediacorrespondsto
a milder, generally transfusion-independent form with later clinical
onset [1]. Transfusion therapy in b-thalassemia major patients
requires adequate iron chelation treatments to avoid its progressive
accumulation in several organs, evoking subsequent tissue damage
and, eventually, death.
Although lifelong blood transfusions combined with adequate
chelation therapy have significantly improved the survival of b-
thalassemia major patients, cardiac complications remain the main
cause of mortality in both b-thalassemia major and intermedia [1–
3]. In addition, arterial and venous thromboembolic events in b-
thalassemia major patients have been reported [4]. Several
pathogenic factors contribute to these complications, including a
chronic hypercoagulable state [5], increased erythrocyte aggrega-
tion [6] and endothelial adhesion of thalassemic erythrocytes in
microvessels [7]. Furthermore, in vivo evidence of endothelial cell
activation [8,9] and impaired flow-mediated dilation in the
brachial arteries of b-thalassemic patients [10,11] implicate
endothelial dysfunction in the pathogenesis of the above-
mentioned vascular complications. Studies have revealed flow-
mediated endothelial dysfunction in conduit arteries of optimally-
chelated, transfusion-dependent b-thalassemic patients [10–12].
However uncertainty remains regarding the integrity of resistance
artery endothelial vasomotor function. In addition, while these
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bioavailability, the underlying mechanisms of endothelial dysfunc-
tion and the specific role of enzymatic NO synthase (NOS)
expression have yet to be elucidated.
Endothelial dysfunction generally leads to vascular remodeling
[13], namely, arterial structural alterations and, consequently,
potential changes in mechanical properties. In b-thalassemic
patients, ultrasonographic measurements have demonstrated
impaired elastic properties of the aorta [14,15] and carotid
arteries [11], suggesting reorganization of the vascular wall
involving smooth muscle cells, elastin and collagen. Such a
hypothesis, however, remains to be verified with experimental
evidence and without the potential confounding impact of iron
accumulation in vascular tissue.
Several b-thalassemic mouse models replicating phenotypic
aspects and hematological anomalies of b-thalassemia major have
been produced to characterize the pathogenesis and development
of potential therapeutic strategies. To date, however, no studies
have investigated vascular function and structure in b-thalassemic
mice. In addition, the vasculature in b-thalassemia has not yet
been examined without the confounding effects of transfusions and
subsequent transfusional iron overload. The objectives of this
study were to gain mechanistic insight into resistance artery
vascular function by characterizing the NO-dependent endothelial
vasodilatory function of isolated mesenteric arteries, and by
evaluating carotid artery mechanical properties and structure in
a non-transfused mouse model of b-thalassemia major.
Methods
Experimental Animals
Experimental procedures, including ex vivo sample analyses,
were conducted in accordance with guidelines of the Institutional
Animal Care Committee of the University of Montreal Hospital
Research Center. The investigation conformed with guidelines of
the Canadian Council on Animal Care and the Guide for the Care
and Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85-23, revised 1996,
Assurance Number A5377-01).
Male homozygous b-thalassemic (homo-bthal, Hbb
d3(th)/d3(th))
and bone marrow-transplanted control mice (Hbb
+/+) were
generated, as described previously [16]. Briefly, control C57BL/
6J mice from Jackson Laboratories (Bar Harbor, ME) and b-
thalassemic mice homozygous for deletion of the murine b-major
gene (Hbb
d3(th)/d3(th)) [17] were bred onto the C57BL/6J
background for .16 generations. Bone marrow cells harvested




+/+) donors were injected (1.8610
6
cells) into sub-lethally-irradiated (8.75 Gy, Mark I-68A-1 Research
Irradiator, San Francisco, CA), 2-month-old C57BL/6J-Gpi1
b
recipients. Bone marrow engraftment was evaluated in both mouse
groups 2–5 months after transplantation. Only recipients display-
ing complete hematopoietic engraftment were included in the
study, i.e. recipients with the sole expression of either hemoglobin
minor for homo-bthal mice or the specific glucose phosphate
isomerase isotype marker Gpi1
a for the controls.
Hematocrit levels were quantified in 14-month-old mice
immediately before sacrifice. The animals were euthanized by
CO2 inhalation, and the entire intestine as well as the left common
carotid artery were quickly dissected and placed in ice-cold
physiological saline solution (PSS). The abdominal aorta was also
dissected, blotted dry, frozen quickly in liquid nitrogen and kept at
280uC until assayed. The heart, lungs and spleen were excised,
blotted dry and weighed.
Functional Studies of Resistance Arteries
Second-order branches of the mesenteric arteries (,150–
250 mm in diameter) from 10 control and 9 homo-bthal mice
were carefully dissected from all adherent connective tissue of the
intestine and bathed in a 5 mL organ chamber containing PSS of
the following composition (in mmol/L) –118 NaCl, 25 NaHCO3,
4.7 KCl, 1.18 KH2PO4, 1.18 MgSO4, 2.5 CaCl2, 0.026 EDTA
and 5.5 glucose – maintained at pH 7.4, warmed to 37uC and
bubbled continuously with 12% O2,5 %C O 2, and 83% N2. Each
arterial segment was mounted and secured on 2 glass micro-
cannulae with nylon ties, in a video-monitored pressure arterio-
graph system (Living Systems, Burlington, VT). The arteriograph
system was placed on the stage of an inverted microscope (Nikon
Eclipse TS100, Melville, NY) equipped with a video camera to
monitor and measure vessel lumen diameter. The distance
between moving cannulae was adjusted carefully to obtain
horizontal vessel alignment without further stretching. Experi-
mental assessment was started 1 hr after equilibration at
45 mmHg intraluminal pressure. Between each protocol described
next, the system was washed out with PSS, re-equilibrated for
30 min, and resting lumen diameter was recorded. Vascular
contractile reactivity was evaluated with dose-response curves to
norepinephrine (NE, 10
29 to 10
24 mol/L, Sigma-Aldrich, St.
Louis, MO). Endothelium-dependent and independent relaxation
in response to cumulative concentrations of acetylcholine (ACh,
10
29 to 10
24 mol/L) and sodium nitroprusside (SNP, 10
29 to
10
23 mol/L), respectively, was determined by measuring the
dilatory responses of vessels pre-contracted with a sub-maximal
NE concentration (which produced 75 to 80% of maximal
contraction, i.e. EC75–EC80). To study the contribution of NO to
ACh-induced relaxation, concentration-response measurements
were repeated after 30- min pre-incubation with Nv-nitro-L-
arginine methyl ester (L-NAME, 10
24 mol/L). Relaxation was
considered as a percentage of lumen diameter increased from
resting diameter.
Mechanical Studies of Carotid Arteries
The left carotid arteries of 13 controls and 11 homo-bthal mice
were mounted in the pressure arteriograph system, adjusted to
their in vivo length by displacing cannulae, and de-activated by
perfusion with warmed and continuously-bubbled Ca
2+-free PSS
containing 10 mmol/L EGTA for 45 min at 45 mmHg. Intralu-
minal pressure was then raised 3 times from 3 to 140 mmHg to
unbuckle the arteries. Vascular mechanics were evaluated by
increasing intraluminal pressure from 3 to 180 mmHg by steps of
10 mmHg (except for the first step which was from 3 to
10 mmHg). For each pressure step, lumen diameter and wall
thickness were measured by microscopy at 3 different positions
along the vessel.
Carotid vascular wall cross-sectional area (CSA) was calculated
as: (p/4)6(De
2–Di
2), where De and Di represent external and
intraluminal diameters, respectively. The wall-to-lumen ratio was
calculated as 2W/Di, where W is wall thickness. Circumferential
strain (e) was determined as (Di2Di(0))/Di(0), where Di(0) is lumen
diameter at 3 mmHg. Circumferential stress (s) was given by
(P6Di)/(2W) [18], where P is intraluminal pressure in dynes/cm
2.
Exponential fitting regression was performed on the stress-strain
relationship of each vessel with the equation s=s0 e
be, where
amplitude s0 stands for stress at diameter Di(0) and exponent b is
the rate of increase of the stress-strain curve. This exponential
model deduced the tangential elastic modulus (TEM) given by
ds/de=bs. Therefore, b also represents the slope of the TEM-to-
stress relationship and thus reflects the non-linear elastic properties
Vascular Biomechanics in b-Thalassemia
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stiffness.
Protein Expression Analysis
Frozen abdominal aortae (n=6 per group) were pulverized
separately in the presence of liquid nitrogen, and the powder was
homogenized in lysis buffer (pH 8) containing 20 mmoles/L Tris-
HCl, 150 mmoles/L NaCl, 2 mmoles/L EDTA and 0.5% Triton
6100 supplemented with protease inhibitor cocktail (No. P8340,
Sigma-Aldrich) and phenylmethylsulfonyl fluoride (PMSF,
1 mmole/L final concentration). The samples were incubated for
30 min on ice and centrifuged at 4uC for 5 min. The supernatants
were collected and stored at 220uC. Protein concentrations of the
lysateswerequantifiedbyspectrophotometricBradfordproteinassay
(No. 500–0006, Bio-Rad, Mississauga, ON, Canada) with bovine
serum albumin as standard. Protein lysates of bovine aortic
endothelial cells (BAEC; 2 mg) served as positive controls. Equal
amountsofaorticprotein(20 mg/lane,exceptforBAECcontrollane)
wereloaded,separatedbysodiumdodecylsulfatepolyacrylamidegel
electrophoresis (SDS-PAGE) with the Novex 8% Tris-Glycine Pre-




The membrane was incubated with primary mouse monoclonal
antibody against endothelial NOS (eNOS) (1:500; No. 610296, BD
Transduction Laboratories, Mississauga, ON, Canada) for 2 hr at
4uC, washed 3 times (5 min each) in PBST and incubated with
secondary antibody (peroxidase conjugated anti-mouse immuno-
globulin 1:5,000; No. A4416, Sigma-Aldrich) for 1 hr at 4uC. The
membranewasthenwashed3timesfor5 mininPBST,andthesignal
was detected by an ECL Western blotting system (No. RPN2132,
Amersham,Baied’Urfe ´,QC,Canada).Bandintensitywasquantified
and expressed as a percentage of control band intensity. Constitu-
tively-expressed protein GAPDHwas the internal control.
Histopathology Analysis
At the end of the mechanical experiments, the common carotid
arteriesfromcontrolandhomo-bthalmice(n=8ineachgroup)were
fixed overnight in 10% phosphate-buffered formalin, embedded in
paraffin and cut serially in 5-mm cross-sections. Tissue sections were
stained with Verhoeff van Gieson for elastin. Images of all sections
were taken under transmitted light at the same light intensity and
exposure time settings. Six sections per vessel were analyzed. The
relativeelastinsurfaceinthemediawasassessedsemi-quantitatively
by computer-assisted post-processing (Matlab software, version 7,
release 14,MathWorks Inc., Natick,MA).
Statistical Analyses
The data are presented as mean 6 SEM. Statistics on the dose-
response curves and mechanical parameters were analyzed by 2-
way analyses of variance (ANOVA) for repeated measures,
followed by the Student-Newman-Keuls test for multiple compar-
isons with post-hoc investigation. Histological elastin content and
protein expression data were analyzed by unpaired Student’s t
tests. p,0.05 was considered significant.
Results
Fourteen-month-old homo-bthal mice were severely anemic
and displayed significant splenomegaly, as described for human b-
thalassemia major. Homo-bthal mice also had lower body weight
and increased lung and heart weights normalized to body weight
compared to the controls (Table 1). The 65% increment in
normalized heart weight is indicative of cardiac hypertrophy, a
phenotype consistent with severe clinical b-thalassemia [19].
Endothelial Vasomotor Function Impairment in Homo-
bthal Mesenteric Arteries
Vascular function was assessed in isolated mesenteric arteriole
preparations from 14 month-old control (n=10) and homo-bthal
(n=9) mice. NE-mediated vascular contraction was similar in both
groups (data not shown). Endothelium-dependent vasodilation in
response to ACh, however, was significantly impaired in the
arterioles of homo-bthal mice with a maximum response of
71.168.2% compared to 105.463.7% for control mice
(Figure 1A). In contrast, endothelium-independent relaxation
stimulated by SNP was almost identical in homo-bthal and
control arterioles (Figure 1B). Although inhibition of NO synthesis
by L-NAME reduced ACh-induced vasodilation in arterioles of
both mouse groups, this suppressive effect was significantly lower
in homo-bthal mice (p,0.05) than in the controls (32.368.7% vs.
55.566.1% inhibition of the maximum response, respectively,
Figure 2). Therefore, our results indicate preserved smooth muscle
cell function in b-thalassemic mice with endothelial vasodilatory
dysfunction and decreased NO bioavailability.
Overexpression of Vascular eNOS Protein in Homo-bthal
Mice
By aortic Western blot analysis, we assessed whether the
alterations in endothelium-dependent vasodilation were secondary
to changes in eNOS expression. Homo-bthal mice presented a 2-
fold increase in eNOS expression versus the controls (p,0.05,
Figure 3). Thus, the afore-mentioned endothelial dysfunction and
decrease in NO bioavailability occurred despite eNOS up-
regulation.
Alterations in Carotid Artery Vascular Mechanics in
Homo-bthal Mice
The mechanical properties of carotid arteries in control (n=13)
and homo-bthal (n=11) mice were studied by correlating passive
changes in vascular diameters with step-wise increments in
intraluminal pressure. The carotid arteries of both groups
displayed similar increases in luminal diameter in response to
augmented intraluminal pressure from 3 to 180 mmHg
(Figure 4A). Carotid external diameters in homo-bthal mice were
significantly larger at all intraluminal pressures (Figure 4B),
reflecting vascular wall thickening and significantly higher wall
CSA (Figure 4C). The increased wall-to-lumen ratios in homo-
bthal mice compared to the controls are indicative of carotid
Table 1. Characteristics of 14-month-old mice.
Control Homo-bthal
(n=13) (n=11)
BW (g) 32.761.3 28.160.8
*
Hct (%) 41.961.1 27.061.2
{
Heart weight to BW (mg/g) 4.560.2 7.360.3
{
Lung weight to BW (mg/g) 4.660.2 5.960.1
{
Spleen weight to BW (mg/g) 2.260.3 11.461.2
{
Values are means 6 SEM.
*p,0.05;
{p,0.001 vs. control mice. BW, body weight; Hct, hematocrit.
doi:10.1371/journal.pone.0038089.t001
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wall stresses were significantly lower in homo-bthal carotid arteries
(Figure 5B) compared to the controls, circumferential strain values
were similar overall in both groups (Figure 5A). Consequently, the
non-linear circumferential stress-strain curve shifted rightward in
the homo-bthal group (Figure 5C), which proves softening of the
arteries in comparison to the controls. This was confirmed by
lower mean values of b (slope of the TEM-to-stress relationship) in
homo-bthal mice (3.1160.08, p,0.01) compared to the controls
(3.4360.05). Softening of carotid artery structural components
was further proven by semi-quantitative histological analysis with
Verhoeff van Gieson staining, revealing that the relative surfaces
of elastin in the media of homo-bthal carotids were significantly
increased compared to the controls (Figure 6A and B, p,0.05).
Discussion
For the first time, the present study investigated the endothe-
lium-mediated NO vasodilation response in resistance arteries as
well as the mechanical properties and structure of the common
carotid arteries in b-thalassemic mice. Our results confirmed that:
1) b-thalassemic mice, homozygous for deletion of the murine b-
major gene, display significant impairment of resistance arteriole
endothelial-dependent vasodilator function in conjunction with
heightened levels of eNOS expression and preserved smooth
Figure 1. Vasodilatory responses of mesenteric resistance arterioles to acetylcholine (ACh) (A) and sodium nitroprusside (SNP) (B),
in control (#; n=10) and homo-bthal (N; n=9) mice. Relaxation responses are expressed as a percentage increase in lumen diameter after
norepinephrine pre-contraction. Data are means 6 SEM.
*p,0.05.
doi:10.1371/journal.pone.0038089.g001
Figure 2. Endothelium-dependent vasodilatory responses of mesenteric resistance arterioles from control (n=10) (A) and homo-
bthal mice (n=9) (B) to acetylcholine (ACh) in the absence (#) or presence (m) of L-NAME. Relaxation responses are expressed as a
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Figure 4. Comparison of structural characteristics in common carotid arteries from control (#; n=13) and homo-bthal mice (N;
n=11). (A) Luminal diameter, (B) external diameter, (C) wall cross-sectional area (CSA), and (D) wall-to-lumen ratio versus intraluminal pressure. Data
are means 6 SEM.
{p,0.001.
doi:10.1371/journal.pone.0038089.g004
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38089Figure 5. Comparison of mechanical parameters in common carotid arteries from control (#; n=13) and homo-bthal mice (N; n=11).
Circumferential strain-intraluminal pressure (A), circumferential stress-intraluminal pressure (B), and stress-strain (C) relationships. Data are means 6
SEM.
{p,0.001. The curve in panel C exhibits a rightward shift in the homo-bthal group, as shown by a significant decrease in b (p,0.01) and the
slope of the tangential elastic strain modulus-to-stress relationship.
doi:10.1371/journal.pone.0038089.g005
Figure 6. Histological analysis of elastin content in media (A) and representative microscopy images of Verhoeff van Gieson-
stained sections (B) of the left common carotid arteries in control (open bars) and homo-bthal mice (closed bars, n=8 per group).
Data are means ± SEM.
*p,0.05. L, vascular lumen.
doi:10.1371/journal.pone.0038089.g006
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thalassemic mice are characterized by wall thickening and
softening of structural components with increased elastin content.
Endothelium-dependent Vascular Reactivity
Previous clinical studies have suggested that endothelial
dysfunction in the conduit arteries of b-thalassemic patients is
due to decreased NO bioavailability [10]. Our results on resistance
arterioles are consistent with this possibility, since we observed
attenuated endothelium-dependent vasodilation in response to
ACh in b-thalassemic mice. NO bioavailability is determined by a
balance between NO production and consumption. Our results
present, for the first time, that endothelial dysfunction in b-
thalassemia occurs despite increased eNOS expression levels. This
suggests either impaired NOS activity or increased NO scaveng-
ing. b-thalassemia is associated with chronic intravascular
hemolysis that is known to induce de-compartmentalization of
two main erythrocyte components into plasma: hemoglobin and
arginase [20]. Cell-free plasma hemoglobin reacts rapidly with,
and deactivates, NO [21]. It has been shown to elicit a significant
decrease of NO bioavailability in vivo and endothelial dysfunction
[22] by limiting NO diffusion from the endothelium to smooth
muscle cells and, consequently, inhibiting vasodilation. While this
mechanism of NO-scavenging is likely to contribute to further
declines of NO bioavailability in b-thalassemia in vivo, it does not
apply to the current experimental ex vivo setting of isolated
mesenteric arterioles. However, spontaneous release of erythrocyte
arginase during intravascular hemolysis may limit cellular
availability of the eNOS substrate for NO synthesis, L-arginine,
resulting in deficient NO production. In fact, studies of patients
affected by sickle cell disease, another hemoglobinopathy inducing
chronic hemolytic anemia, have shown increased intravascular
hemolysis-related plasma arginase activity [20]. In b-thalassemia
patients, heightened erythrocyte arginase activity strongly corre-
lating with plasma arginase activity has also been reported [23]. In
b-thalassemic arteries, decreased plasmatic L-arginine should lead
to reduced cellular uptake of the substrate and consequent
alteration of NO production despite increased eNOS expression.
Moreover, further diminution of NO bioavailability may result
from increased oxidative stress. A common mechanism of
endothelial dysfunction in hemolytic anemias has been suggested
by studies of b-thalassemia [24], sickle cell disease [25] and mouse
models of severe hemolysis [26] reporting the increased oxidizing
potential of plasma, possibly generated directly by cell-free
hemoglobin, heme and heme-iron [27], which might damage
and activate the endothelium by evoking oxidative injury. In
addition, enzymatic pathways of reactive oxygen species (ROS)
overproduction – of superoxide, for example – by activating vessel
wall xanthine oxidase and NADPH oxidase, have been postulated
to play a role in the generation of oxidative stress in both b-
thalassemia and sickle cell disease [20]. Finally, the paradoxical
decrease in NO production, even though eNOS levels were
elevated, might reflect an eNOS uncoupling mechanism. The
possible decrease in L-arginine availability might culminate in
eNOS dimer disruption or uncoupling, causing superoxide instead
of NO production [28,29] and further adding to the reduction of
NO bioavailability as well as increased oxidative stress in b-
thalassemia.
Endothelium-independent Vascular Reactivity
In addition, a discrepancy with respect to previous clinical
investigations was reported concerning endothelium-independent
vasodilation in b-thalassemia [10,11,30]. Indeed, our findings
confirm preserved endothelium-independent vasodilation in re-
sponse to SNP, a direct donor of NO metabolized by smooth
muscle cells. This important insight indicates that resistance
arteriole vasodilatory impairment occurs in the absence of vascular
smooth muscle cell dysfunction in NO signaling at the level of the
guanylate cyclase-cGMP system. Therefore, vascular dysfunction
in our b-thalassemic mice does not seem to be associated with NO
resistance or lack of responsiveness.
Carotid Artery Structure and Mechanical Properties
The b-thalassemia major mouse model not only presented
resistance arteriole endothelial-mediated vasomotor dysfunction
but also displayed altered carotid artery structure with changes in
the mechanical properties of wall components. Our study
demonstrated the development of carotid artery wall hypertrophic
remodeling characterized by an increase in both total wall
thickness and wall-to-lumen ratios. This wall thickening was
coupled with growth of medial elastin content within the b-
thalassemic carotid artery wall.
Clinical studies of b-thalassemia major patients have reported
increased arterial stiffness of the carotid arteries [11,31], brachial
arteries [11,12], ascending [14] and abdominal aortae [32]. The
explicative mechanisms of discrepancy between these clinical and
our murine b-thalassemia vascular mechanical results remain
unknown and require further investigation. Nevertheless, clinical
studies have demonstrated that stiffness of the abdominal aorta in
regularly-transfused b-thalassemia major patients was increased in
relation to liver iron concentration, a reliable indicator of tissue
iron-loading [32]. Iron overloading has been known to augment
systemic and vascular wall ROS generation, which might
contribute to the development of vascular injury [33]. These
findings led us to hypothesize that the b-thalassemic vasculature
remodels differently in the absence of palliative transfusion
treatments, evoking iron-overloading.
Anemia-induced hypoxia and oxidative damage might have
contributed to arterial structural changes in b-thalassemic mice. In
fact, hypoxia is known to promote vascular cellular proliferation
and matrix synthesis by inducing a variety of genes in endothelial
cells, eliciting the production of mitotic factors, such as platelet-
derived growth factor B, insulin-like growth factor and vascular
endothelial growth factor [34]. In addition, studies have indicated
that ROS might provoke vascular structural and functional
alterations by activating several intracellular signaling cascades,
namely, extracellular signal-regulated kinases, mitogen-activated
protein kinases, tyrosine kinases, protein tyrosine phosphatases
and transcriptional factors, such as nuclear factor kappa B and
activated protein 1 [35].
In conclusion, our study of non-transfused b-thalassemic mice
provided evidence of functional changes in endothelium-depen-
dent vascular responses characterized by dysregulation of endo-
thelial NO production and consequent NO bioavailability. In
addition, endothelial dysfunction of resistance arterioles occurred
concomitant to structural alterations of the carotid artery wall and
modification of the mechanical properties of wall components.
Hemolysis likely contributed to the pathophysiology of both
endothelial dysfunction as well as vascular structural and
mechanical changes in b-thalassemia. Treatments targeting
hemolysis-related complications, namely, erythrocyte de-compart-
mentalization of hemoglobin and arginase, may represent
potential therapeutic strategies. Future investigations with this
mouse model should provide a better understanding of underlying
molecular processes in the pathogenesis of b-thalassemia major
vasculopathy.
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